does retatrutide help diabetes More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Retatrutide is being called the

A meta-analysis which included eight trials with a total of 60,080 patients found that GLP-1 agonists reduced major adverse cardiovascular events, all-cause mortality and hospital admissions for heart failure in treated patients with type 2 diabetes, regardless of structural homology 20

It is a tripeptide, which is a fancy way of saying it is made up of three specific amino acids: glutamine, cysteine, and glycine

In a 52-week trial, tirzepatide resolved NASH in 4462% of participantscompared to only 10% on placeboand improved liver scarring

Leaders in personalized solutions

It was essential that the new platform not only embodied Fridays brand and mission but also felt intuitive and personalized for each patient